“…While the in vitro fibrils show polymorphism, the fibril from patients is not polymorphic (Lu et al, 2013). These novel structural data will open new avenues for a structure-based design of diagnostic imaging agents and aggregation inhibiting drugs (Aguzzi & Gitler, 2013;Lu et al, 2013) and will certainly initiate future computer-aided design of drugs by combining techniques such as QSAR, docking with molecular dynamic simulations (Alonso, Bliznyuk, & Gready, 2006;Berhanu, Pillai, Oliferenko, & Katritzky, 2012). Such combinations have already been proved to reduce the costs and to increase the speed of drug discovery, and their importance will only grow further in future (Sliwoski, Kothiwale, Meiler, & Lowe, 2014).…”